Resistance Exercise Training in the Older Population With Obesity
Launched by UNIVERSIDAD DE LA FRONTERA · Apr 11, 2024
Trial Information
Current as of August 21, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a 12-week resistance exercise training program on older women aged 60 to 79 years, focusing on how it affects muscle quality, immune response, and physical performance. The researchers want to see if this type of strength training can help improve muscle health, especially in women with obesity compared to those of normal weight. They believe that women with obesity may start with more challenges, but they could also see greater improvements after the training.
To participate, women must be between 60 and 79 years old, live in the community (not in nursing homes), and fall into either the normal weight or obese categories based on their body mass index (BMI). Participants will work out three times a week for 12 weeks, and their progress will be measured before and after the program using various tests. This study aims to help understand how exercise can benefit older women, especially those dealing with obesity.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Older women between 60 and 79 years old who live in the community, that is, they do not live in nursing homes or similar.
- • Older people with normal weight (BMI=18.5 to 24.9 kg/m2 and % fat \<25.9) and those with obesity (BMI= 30 to 39.9 Kg/m2 and % fat \> 32).
- • Cognitive ability to follow verbal orders.
- Exclusion Criteria:
- • Neuromuscular or mobility disorders that do not allow resistance training to be carried out safely (debilitating arthritis, spasticity/rigidity, neurological disorders and paralysis).
- • Use of nutritional supplementation that can regulate skeletal muscle (leucine, glutamine, casein, whey-protein, fatty acids and creatine).
- • Untreated and/or uncontrolled chronic diseases.
- • Have carried out a training program with resistance exercises in the last 6 months.
About Universidad De La Frontera
Universidad de la Frontera is a distinguished academic institution dedicated to advancing health sciences through innovative research and clinical trials. Located in Chile, the university fosters a collaborative environment that integrates multidisciplinary expertise to address pressing health challenges. With a commitment to ethical standards and patient safety, Universidad de la Frontera actively engages in clinical research aimed at improving healthcare outcomes and contributing valuable insights to the global medical community. Its robust research infrastructure and emphasis on education position it as a leader in the field of clinical trials and translational medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Temuco, , Chile
Temuco, Ix Región De La Araucanía, Chile
Temuco, Araucanía, Chile
Temuco, , Chile
Patients applied
Trial Officials
GABRIEL MARZUCA, Msc, PhD
Study Director
Universidad de La Frontera. Temuco, Chile
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported